Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|February 24, 2004
Co-inheritance of Hb Pak Num Po, a novel alpha1 gene mutation, and alpha0 thalassemia associated with transfusion-dependent Hb H diseaseVip Viprakasit, Voravarn S Tanphaichitr, Gavivann Veerakul, et al.
Blood|October 25, 2003
Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndromeDavid P Steensma, Vip Viprakasit, Alex Hendrick, et al.
Hemoglobin|November 28, 2012
A single-tube multiplex gap-polymerase chain reaction for the detection of eight β-globin gene cluster deletions common in Southeast AsiaJaruwan Tritipsombut, Marion Phylipsen, Vip Viprakasit, et al.
British Journal of Haematology|December 6, 2016
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusionsJohn B Porter, Maria Domenica Cappellini, Antonis Kattamis, et al.
Blood Cells, Molecules & Diseases|April 28, 2010
Natural history of Southeast Asian Ovalocytosis during the first 3 years of lifeVichai Laosombat, Vip Viprakasit, Supaporn Dissaneevate, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 21, 2015
Human primary erythroid cells as a more sensitive alternative in vitro hematological model for nanotoxicity studies: Toxicological effects of silver nanoparticlesNarawadee Rujanapun, Sasitorn Aueviriyavit, Suwimon Boonrungsiman, et al.
Pediatric Blood & Cancer|May 16, 2024
Iron chelation therapy for children with transfusion-dependent β-thalassemia: How young is too young?Gian Luca Forni, Antonis Kattamis, Kevin H M Kuo, et al.
European Journal of Internal Medicine|November 8, 2015
Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemiaM Domenica Cappellini, John B Porter, Khaled M Musallam, et al.
Orphanet Journal of Rare Diseases|November 26, 2025
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a studyAntonis Kattamis, Ali Taher, Vip Viprakasit, et al.
Clinical Chemistry and Laboratory Medicine|March 26, 2013
Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: a lesson from ThailandVip Viprakasit, Chanin Limwongse, Sathein Sukpanichnant, et al.
Pageof 16